Thus, these findings indicate that LACK156‐173 could potentially suppress fatty acid synthesis metabolism, restore lipid metabolism balance, and reduce the activation of the AKT/NF‐κB pathway induced by ROS, ultimately attenuating the aggressive phenotype of RA‐FLSs. This evidence concerns the gene NFKB1 and rheumatoid arthritis.